US2019083383A1PendingUtilityA1
Compositions for treatment of xerostomia and for tooth treatment
Individually held — no corporate assignee on recordPriority: Mar 14, 2013Filed: Nov 21, 2018Published: Mar 21, 2019
Est. expiryMar 14, 2033(~6.6 yrs left)· nominal 20-yr term from priority
Inventors:Devin J. Okay
A61P 1/02A61K 8/66A61K 8/0216A61K 8/22A61K 35/57A61K 8/24A61K 8/925A61K 8/981A61K 8/0233A61K 8/553A61Q 11/00A61K 8/361
61
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present application provides an oral care composition comprising: a) emu oil; and one or more of the following: b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents; e) one or more whitening agents.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An oral care composition comprising:
a) emu oil; and one or more of the following: b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents; e) one or more whitening agents.
2 . The composition of claim 1 comprising:
a) emu oil;
and two or more of the following:
b) one or more emulsifying agents;
c) one or more protease enzymes;
d) one or more soluble calcium phosphate remineralizing agents;
e) one or more whitening agents.
3 . The composition of claim 2 comprising:
a) emu oil;
and three or more of the following:
b) one or more emulsifying agents;
c) one or more protease enzymes;
d) one or more soluble calcium phosphate remineralizing agents;
e) one or more whitening agents.
4 . The composition of claim 3 comprising:
a) emu oil;
b) one or more emulsifying agents;
c) one or more protease enzymes;
d) one or more soluble calcium phosphate remineralizing agents;
e) one or more whitening agents.
5 . The composition of claim 4 , wherein one or more of the protease enzymes are selected from the group consisting of papain, trypsin, chymotrypsin, aminopeptidase, carboxypeptidase, pepsin, and cathepsin.
6 . The composition of claim 4 , wherein the one or more whitening agents are selected from the group consisting of carbamide peroxide and hydrogen peroxide.
7 . The composition of claim 4 , wherein the one or more soluble calcium phosphate remineralizing agents are selected from the group consisting of dibasic calcium phosphate, monocalcium phosphate, tricalcium phosphate, and tetracalcium phosphate.
8 . The composition of claim 7 , wherein the one or more emulsifying agents are phospholipids.
9 . The composition of claim 8 , wherein the phospholipids are lecithin.
10 . The composition of claim 4 , wherein the composition further comprises an isomalt.
11 . The composition of claim 10 , wherein the isomalt is selected from the group consisting of galenIQ™ 720 and galenIQ™ 721.
12 . The composition of claim 4 , wherein the composition further comprises a disintegrating agent.
13 . The composition of claim 12 , wherein the disintegrating agent is crospovidone.
14 . The composition of claim 4 , wherein the composition further comprises magnesium stearate.
15 . The composition of claim 4 , wherein the composition further comprises glycerin.
16 . The composition of claim 4 , wherein the composition further comprises fluoride.
17 . The composition of claim 4 , wherein the remineralizing agent is white in color.
18 . The composition of any one claims 1 - 17 , wherein the composition is formulated as a tablet, a bilayer tablet, a multilayer tablet, chewing gum, a toothpaste, a lozenge, a powder, a gel, a viscous gel, an ointment, a cream, a liquid, a mouthwash, or a candy.
19 . The composition of claim 18 , wherein the composition is formulated as a bilayer tablet.
20 . The composition of claim 19 , wherein the bilayer tablet comprises a rapidly disintegrating layer and a slowly eroding layer.
21 . The composition of claim 20 , wherein the one or more whitening agents are present only in the rapidly disintegrating layer.
22 . The composition of claim 20 , wherein the emu oil and the one or more proteases are present only in the slowly eroding layer.
23 . The composition of claim 20 , wherein the one or more whitening agents are present only in the rapidly disintegrating layer; and the emu oil and the one or more proteases are present only in the slowly eroding layer.
24 . The composition of claim 23 , wherein the rapidly disintegrating layer comprises carbamide peroxide in an amount between 0.1 to 10.0% by weight.
25 . The composition of claim 24 , wherein the rapidly disintegrating layer comprises carbamide peroxide in an amount of 1.0% by weight.
26 . The composition of claim 23 , wherein the slowly eroding layer comprises emu oil in an amount between 0.1 to 15% by weight.
27 . The composition of claim 26 , wherein the slowly eroding layer comprises emu oil in an amount of 10% by weight.
28 . The composition of claim 23 , wherein the slowly eroding layer comprises papain in an amount between 0.1 to 20% by weight.
29 . The composition of claim 27 , wherein the slowly eroding layer comprises papain in an amount of 10% by weight.
30 . A method of treating a subject suffering from xerostomia which comprises administering to the subject, in an amount effective to treat the xerostomia, a composition of any one of claims 1 - 29 .
31 . The method of claim 30 , wherein the composition further whitens teeth in the subject's mouth.
32 . The method of claim 30 , wherein the composition further remineralizes teeth in the subject's mouth.
33 . The method of claim 30 , wherein the composition further whitens and remineralizes teeth in the subject's mouth.
34 . The method of claim 30 , wherein the composition further reduces dental sensitivity of the subject.
35 . The method of claim 30 , wherein the composition further treats dental caries of the subject.
36 . The method of any one of claims 30 - 35 , wherein the subject is a human.
37 . The method of any one of claims 30 - 35 , wherein the subject is a non-human animal.
38 . The method of claim 36 , wherein the subject has an autoimmune disease, diabetes, Sjögren's syndrome, or has recently undergone radiation therapy or chemotherapy.
39 . The method of claim 36 , wherein the subject is concurrently taking one or more medications that causes xerostomia.
40 . An oral care composition for whitening teeth comprising one or more whitening agents, wherein the composition is formulated as a bilayer tablet comprising:
(i) a rapidly disintegrating layer; and (ii) a slowly eroding layer, wherein the one or more whitening agents are each oxidizing agents and are each present only in the rapidly disintegrating layer.
41 . The composition of claim 40 , wherein the one or more whitening agents are selected from the group consisting of carbamide peroxide and hydrogen peroxide.
42 . The composition of claim 41 , wherein the whitening agent is carbamide peroxide and is present in an amount between 0.1 to 10.0% by weight of the disintegrating layer.
43 . The composition of claim 41 , wherein the whitening agent is carbamide peroxide and is present in an amount of 1.0% by weight of the disintegrating layer.
44 . The composition of claim 40 , further comprising one or more of the following:
a) emu oil; b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents.
45 . The composition of claim 44 , further comprising two or more of the following:
a) emu oil; b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents.
46 . The composition of claim 45 , further comprising three or more of the following:
a) emu oil; b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents.
47 . The composition of claim 46 , further comprising each of the following:
a) emu oil; b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents.
48 . The composition of claim 40 , further comprising:
a) emu oil; and one or more of the following: b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents.
49 . The composition of claim 47 , wherein the emu oil, the one or more emulsifying agents, and the one or more protease enzymes are present only in the slowly eroding layer.
50 . The composition of claim 47 , wherein the one or more soluble calcium phosphate remineralizing agents are present only in the rapidly disintegrating layer.
51 . A method of treating a subject suffering from xerostomia which comprises administering to the subject, in an amount effective to treat the xerostomia, a composition of claim 48 .
52 . A method of whitening teeth in a subject's mouth which comprises administering to the subject's teeth, in an amount effective to whiten the teeth, a composition of any one of claims 40 - 50 .
53 . An oral care composition comprising:
a) one or more omega fatty acids; and one or more of the following: b) one or more emulsifying agents; c) one or more protease enzymes; d) one or more soluble calcium phosphate remineralizing agents; e) one or more whitening agents.
54 . The composition of claim 53 comprising:
a) one or more omega fatty acids;
and two or more of the following:
b) one or more emulsifying agents;
c) one or more protease enzymes;
d) one or more soluble calcium phosphate remineralizing agents;
e) one or more whitening agents.
55 . The composition of claim 54 comprising:
a) one or more omega fatty acids;
and three or more of the following:
b) one or more emulsifying agents;
c) one or more protease enzymes;
d) one or more soluble calcium phosphate remineralizing agents;
e) one or more whitening agents.
56 . The composition of claim 55 comprising each of the following:
a) one or more omega fatty acids;
b) one or more emulsifying agents;
c) one or more protease enzymes;
d) one or more soluble calcium phosphate remineralizing agents;
e) one or more whitening agents.
57 . The composition of any one of claims 53 - 56 , wherein the one or more omega fatty acids comprise omega-3 fatty acids or omega-6 fatty acids.
58 . The composition of claim 57 , wherein the omega-3 fatty acid is alpha-linoleic acid and the omega-6 fatty acid is gamma-linoleic acid.
59 . A method of treating a subject suffering from xerostomia which comprises administering to the subject, in an amount effective to treat the xerostomia, a composition of claim 53 .
60 . A method of whitening teeth in a subject's mouth which comprises administering to the subject's teeth, in an amount effective to whiten the teeth, a composition of claim 56 .Join the waitlist — get patent alerts
Track US2019083383A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.